About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

US Inhaled Insulin Therapeutic Choice Questionnaire Study

NCT00139763·42 sites·ClinicalTrials.gov

What this study is about

Take this into the appointment.

Saves the questions and what to expect into your notes, next to the visit they belong to.

Keep this study

Lead

Pfizer

With

Sanofi

Age

18–80

Sex

ALL

Healthy volunteers

Not accepted

You may be eligible if

Male and female, age \> = 18 years and \<= 80 years with a diagnosis of type 2 diabetes made at least 6 months prior to study entry
Currently treated with either:
2 or more oral antidiabetic agents, OR 1 or more oral antidiabetic agents and insulin glargine

You may not be if

Type 1 diabetes
Smoking within the past 6 months

The record

StatusCompleted

PhasePhase 3

Taking part740

StartedJul 2005

UpdatedMar 19, 2007

Conditions

Diabetes Mellitus, Type 2

Where42

Pfizer Investigational Site
Chandler, Arizona, United States
Pfizer Investigational Site
Mesa, Arizona, United States
Pfizer Investigational Site
Phoenix, Arizona, United States

Clareo Health | US Inhaled Insulin Therapeutic Choice Questionnaire Study